The North America Facial Aesthetics Market is expected to witness market growth of 13.7% CAGR during the forecast period (2022-2028).
For facial aesthetics, a variety of products are available, including chemical peels, cosmetic implants, dermal fillers, Botulinum toxin, and microdermabrasion. The applications of facial aesthetic therapy comprise lip augmentation, facial line correction, scar treatment, wrinkle reduction, and face lifting. Scars, blemishes, and facial wrinkles can all be diminished with laser skin resurfacing. Microdermabrasion is a minimally invasive process used to enhance the overall tone and texture of the skin.
This procedure has several advantages and uses a modestly harsh device to carefully remove the thicker, uneven outer layer. Additionally, a rise in young people's self-awareness regarding physical attractiveness fuels the need for facial aesthetic treatments. Increased sedentary behavior among young people also contributed to appearance problems, like facial hair and pigmentation, making them more self-conscious and driving up demand for facial aesthetic procedures.
Governments in regional countries are continuously working on the improvement of their healthcare infrastructure. For example, according to the Canadian Institute for Health Information, the United States spends more than any other country on healthcare services. On average, it spends more per person than the other OECD nations. These expenses are paid for by a diverse range of public payers, including the state, federal, and local governments, private insurance, and individual contributions. There is not a solitary national health insurance program.
The US market dominated the North America Facial Aesthetics Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $4,004.9 million by 2028. The Canada market is poised to grow at a CAGR of 16.3% during (2022 - 2028). Additionally, The Mexico market is expected to witness a CAGR of 15.3% during (2022 - 2028).
Based on Product, the market is segmented into Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels, and Others. Based on Application, the market is segmented into Facial line correction treatment, Scar treatment, Lip enhancement, Restoration of volume or Fullness, and Others. Based on End User, the market is segmented into Hospitals, Specialty & Dermatology Clinics, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Merz Pharma GmbH & Co. KGaA, Galderma S.A., Candela Medical Corporation (Syneron Medical Ltd.), Teoxane S.A., Johnson & Johnson, Cynosure, LLC, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, and Fotona D.o.o.
For facial aesthetics, a variety of products are available, including chemical peels, cosmetic implants, dermal fillers, Botulinum toxin, and microdermabrasion. The applications of facial aesthetic therapy comprise lip augmentation, facial line correction, scar treatment, wrinkle reduction, and face lifting. Scars, blemishes, and facial wrinkles can all be diminished with laser skin resurfacing. Microdermabrasion is a minimally invasive process used to enhance the overall tone and texture of the skin.
This procedure has several advantages and uses a modestly harsh device to carefully remove the thicker, uneven outer layer. Additionally, a rise in young people's self-awareness regarding physical attractiveness fuels the need for facial aesthetic treatments. Increased sedentary behavior among young people also contributed to appearance problems, like facial hair and pigmentation, making them more self-conscious and driving up demand for facial aesthetic procedures.
Governments in regional countries are continuously working on the improvement of their healthcare infrastructure. For example, according to the Canadian Institute for Health Information, the United States spends more than any other country on healthcare services. On average, it spends more per person than the other OECD nations. These expenses are paid for by a diverse range of public payers, including the state, federal, and local governments, private insurance, and individual contributions. There is not a solitary national health insurance program.
The US market dominated the North America Facial Aesthetics Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $4,004.9 million by 2028. The Canada market is poised to grow at a CAGR of 16.3% during (2022 - 2028). Additionally, The Mexico market is expected to witness a CAGR of 15.3% during (2022 - 2028).
Based on Product, the market is segmented into Dermal fillers, Botulinum toxin, Microdermabrasion, Chemical peels, and Others. Based on Application, the market is segmented into Facial line correction treatment, Scar treatment, Lip enhancement, Restoration of volume or Fullness, and Others. Based on End User, the market is segmented into Hospitals, Specialty & Dermatology Clinics, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Merz Pharma GmbH & Co. KGaA, Galderma S.A., Candela Medical Corporation (Syneron Medical Ltd.), Teoxane S.A., Johnson & Johnson, Cynosure, LLC, Bausch Health Companies, Inc., Ipsen Pharma Biotech SAS, and Fotona D.o.o.
Scope of the Study
Market Segments Covered in the Report:
By Product- Dermal fillers
- Botulinum toxin
- Microdermabrasion
- Chemical peels
- Others
- Facial line correction treatment
- Scar treatment
- Lip enhancement
- Restoration of volume or Fullness
- Others
- Hospitals
- Specialty & Dermatology Clinics
- Others
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- AbbVie, Inc.
- Merz Pharma GmbH & Co. KGaA
- Galderma S.A.
- Candela Medical Corporation (Syneron Medical Ltd.)
- Teoxane S.A.
- Johnson & Johnson
- Cynosure, LLC
- Bausch Health Companies, Inc.
- Ipsen Pharma Biotech SAS
- Fotona D.o.o.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. North America Facial Aesthetics Market by Product
Chapter 5. North America Facial Aesthetics Market by Application
Chapter 6. North America Facial Aesthetics Market by End User
Chapter 7. North America Facial Aesthetics Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- AbbVie, Inc.
- Merz Pharma GmbH & Co. KGaA
- Galderma S.A.
- Candela Medical Corporation (Syneron Medical Ltd.)
- Teoxane S.A.
- Johnson & Johnson
- Cynosure, LLC
- Bausch Health Companies, Inc.
- Ipsen Pharma Biotech SAS
- Fotona D.o.o.
Methodology
LOADING...
